Changes of Macular Pigment & Parameters of Eyes After YAG Laser Treatment

Status Completed

Clinical Trial Summary

It has been hypothesized that potential effects of laser Nd: YAG laser posterior capsulotomy may affect macular pigment as well as choroidal thickness, macular thickness and anterior chamber parameters, so it was aimed to investigate possible effects of Nd: YAG laser posterior capsulotomy on macular pigment optical density, choroidal thickness, macular thickness and anterior chamber parameters in cases with posterior capsule opacification in this study.

Clinical Trial Description

This clinical trial was conducted following the principles of the Declaration of Helsinki. The local authorized clinical trials ethics committee approved the protocol and consent forms (Afyon Kocatepe University Clinical Trials Ethics Committee, 2011-KAEK-2 2017/172). Between 2015 and 2016, 38 pseudophakic participants were enrolled in this study. After providing information to patients about the disease and treatment, patients predicted to show adherence to treatment, were enrolled in the study.

Detailed ophthalmological examinations of all subjects were performed prior to Nd: YAG laser posterior capsulotomy intervention. Anterior chamber parameters of cases with PCO were measured Measurements of IOP, anterior chamber parameters, visual acuity, Slit-lamp, gonioscopy and fundus examinations, and measurements of central macular thickness (CMT), choroidal thicknesses (CTs), and MPOD were performed after maximal pupil dilatation.

Proposed procedure, including risks, beneﬁts, and alternatives were discussed with all subjects, and all participants signed of informed consent form.

Choroidal thicknesses were recorded as subfoveal CT (SCT), nasal CT (NCT) and temporal CT (TCT).

MPOD measurements were subsequently made by using luminance differential thresholds test. After measurements a refractive surgery specialist carried out Nd: YAG laser posterior capsulotomy interventions to patients who were decided to applying Nd:YAG laser capsulotomy.

All examinations and measurements were repeated and recorded at 1st week, 1st and 2nd month. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03321253
Study type	Interventional
Source	Afyon Kocatepe University Hospital
Contact
Status	Completed
Phase	N/A
Start date	October 23, 2015
Completion date	May 16, 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03332758` - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Completed	`NCT03660384` - Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy	N/A
Recruiting	`NCT03713268` - Intraoperative OCT Guidance of Intraocular Surgery II
Completed	`NCT04535622` - Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery	N/A
Recruiting	`NCT05863312` - REtinal Detachment Outcomes Study	N/A
Recruiting	`NCT05561569` - Air Versus Gas Tamponade in Primary Retinal Detachment	N/A
Not yet recruiting	`NCT05538156` - Internal Limiting Membrane Peeling in Retinal Detachment Surgery	N/A
Completed	`NCT03046719` - Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal	N/A
Recruiting	`NCT01261533` - Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment	Phase 1
Terminated	`NCT02068625` - Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment	Phase 4
Completed	`NCT00000140` - The Silicone Study	Phase 3
Recruiting	`NCT05543018` - Effect of Intraocular Tamponade on Visual Perception	N/A
Not yet recruiting	`NCT04518696` - Suprachoroidal Buckling for the Management of Rhegmatogenous Retinal Detachment	N/A
Completed	`NCT06166914` - Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment	N/A
Enrolling by invitation	`NCT05566626` - Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera	N/A
Not yet recruiting	`NCT03631108` - Feasibility Study and Preliminary Application Study on Iris OCTA
Recruiting	`NCT02201706` - Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye	N/A
Completed	`NCT03218371` - Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.	N/A
Completed	`NCT00000154` - Diabetic Retinopathy Vitrectomy Study (DRVS)	Phase 3
Recruiting	`NCT05583253` - Visual Outcome of Vitrectomy After Refractive Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms